Rimteravimab

Tax included
Rimteravimab (XVR011) is a bivalent VHH-Fc antibody with potent neutralizing activity with high stability, broad coverage and silenced Fc effector functions against the disease caused by SARS-CoV-2.
MedChemExpress 
HY-P99947

Data sheet

Size
Multiple sizes
Reactivity
SARS-CoV
Application
COVID-19-anti-virus
CAS
2540797-21-3